APA (7th ed.) Citation

X, T., L, S., P, B., X, L., HF, G., J, Y., . . . JM, K. (2021). A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. The Journal of clinical investigation, 131(1), . https://doi.org/10.1172/JCI137186

Chicago Style (17th ed.) Citation

X, Tan, et al. "A Protumorigenic Secretory Pathway Activated by P53 Deficiency in Lung Adenocarcinoma." The Journal of Clinical Investigation 131, no. 1 (2021). https://doi.org/10.1172/JCI137186.

MLA (9th ed.) Citation

X, Tan, et al. "A Protumorigenic Secretory Pathway Activated by P53 Deficiency in Lung Adenocarcinoma." The Journal of Clinical Investigation, vol. 131, no. 1, 2021, https://doi.org/10.1172/JCI137186.